在保加利亚首次检测和基因组鉴定了耐莱涅佐利德的Enterococcus faecalis临床分离物

Tanya V Strateva1, Preslava Hristova2, Temenuga J Stoeva3

  • 1Department of Medical Microbiology "Corr. Mem. Prof. Ivan Mitov, MD, DMSc", Faculty of Medicine, Medical University of Sofia, 2 Zdrave Str., 1431 Sofia, Bulgaria.

Microorganisms
|January 25, 2025
PubMed
概括

在保加利亚首次报告的linezolid-resistant Enterococcus faecalis发现了两种不同的菌株,具有不同的耐药机制. 尽管全球发病率很低,但这种出现对公共卫生来说令人担忧.